Matt Wallach
biomedicine
Veeva Systems
China
Biography
"Matt is president and co-founder of Veeva. Since the company was founded in 2007, Matt has helped Veeva develop as one of the most trusted and trusted partners for the global pharmaceutical industry giants and emerging biotech companies. With its accumulated expertise in the field of life sciences for nearly 20 years, Matt leads the company to meet the most urgent needs of customers in the product development and listing process. Prior to founding Veeva, Matt held leadership positions in product management, marketing, and business development across a variety of healthcare technology companies. Matt served as general manager of Siebel Systems' pharmaceutical and biotechnology department. He has developed Siebel Systems as a market leader in CRM and clinical trial management systems (CTMS) for pharmaceutical companies and later acquired by Oracle. Matt currently works for the HealthVerity board of directors and the Crossix Advisory Board, both of which are leading innovators in medical data and analytics. Matt holds an MBA from Harvard Business School and a Bachelor of Science degree in Economics from Yale University."
Research Interest
medical data and analytics
